Moyle W R, Ehrlich P H, Canfield R E
Proc Natl Acad Sci U S A. 1982 Apr;79(7):2245-9. doi: 10.1073/pnas.79.7.2245.
Monoclonal antibodies were prepared against the alpha and beta subunits of human chorionic gonadotropin (hCG). Although all were selected on the basis of their ability to bind the intact hormone, each also bound one of the two subunits but not both. Using a solid phase double antibody system to measure the relative binding to sites on the surface of hCG, we observed that four of the five antibodies bound to different sites on the molecule. This information was correlated with the ability of each antibody to inhibit the biological activity of hCG. Of the five antibodies tested for their ability to inhibit hCG-induced stimulation of rat testes steroidogenesis in vitro, two proved to be potent inhibitors, whereas the other three had almost no effect. This inhibition of steroidogenesis was highly correlated with the ability of the antibodies to inhibit hCG binding to testes homogenates. Thus, we have begun to derive a scheme that describes the relative binding positions of individual monoclonal antibodies and receptor on hCG. The purified monoclonal antibodies were iodinated and employed to evaluate which antigenic sites on hCG remained free in hCG-receptor complexes. The data indicated that portions of the beta subunit in hCG-receptor complexes were buried (i.e., failed to bind radiolabeled antibody), whereas other portions remained exposed (i.e., they bound radiolabeled antibody). Those antibodies that interacted with portions of hCG that became inaccessible in the receptor complex also blocked the biological actions of hCG, whereas those that interacted with exposed sites had little or no effect on activity. Although we did not find antibodies to the alpha subunit that would bind to the hormone-receptor complex, we found that one of the two antibodies specific to alpha subunit epitopes blocked the actions of the hormone. Both antigenic determinants on the alpha subunit appeared to be lost after the hCG-receptor complex had formed. These studies suggest that each hCG subunit participates in the hormone-receptor complex and that portions of the beta subunit project from the surface of the receptor.
制备了针对人绒毛膜促性腺激素(hCG)α亚基和β亚基的单克隆抗体。尽管所有抗体都是基于它们结合完整激素的能力而挑选出来的,但每一种抗体也只结合两个亚基中的一个,而非两者都结合。利用固相双抗体系统来测量与hCG表面位点的相对结合情况,我们观察到五种抗体中的四种与分子上不同的位点结合。这一信息与每种抗体抑制hCG生物活性的能力相关。在测试的五种抗体中,有两种抗体在体外能够有效抑制hCG诱导的大鼠睾丸类固醇生成,而另外三种几乎没有作用。这种对类固醇生成的抑制与抗体抑制hCG与睾丸匀浆结合的能力高度相关。因此,我们开始推导一个描述单个单克隆抗体和hCG受体相对结合位置的方案。将纯化的单克隆抗体碘化,用于评估hCG-受体复合物中hCG上哪些抗原位点仍未被占据。数据表明,hCG-受体复合物中β亚基的部分区域被掩埋(即无法结合放射性标记抗体),而其他部分仍暴露在外(即它们能结合放射性标记抗体)。那些与hCG中在受体复合物中变得无法接近的部分相互作用的抗体也会阻断hCG的生物学作用,而那些与暴露位点相互作用的抗体对活性几乎没有影响。尽管我们没有找到能与激素-受体复合物结合的α亚基抗体,但我们发现针对α亚基表位的两种抗体中的一种会阻断激素的作用。在hCG-受体复合物形成后,α亚基上的两个抗原决定簇似乎都消失了。这些研究表明,hCG的每个亚基都参与了激素-受体复合物的形成,并且β亚基的部分区域从受体表面突出。